Stocks and Investing Stocks and Investing
Thu, August 11, 2022
Wed, August 10, 2022

Robert Burns Maintained (BNTX) at Strong Buy with Decreased Target to $272 on, Aug 10th, 2022


Published on 2024-10-27 22:35:49 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Maintained "BioNTech SE" (BNTX) at Strong Buy with Decreased Target from $283 to $272 on, Aug 10th, 2022.

Robert has made no other calls on BNTX in the last 4 months.



There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 3 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $194 on, Friday, July 15th, 2022
  • Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold and Held Target at $180 on, Wednesday, June 1st, 2022
  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $206 on, Tuesday, May 24th, 2022


These are the ratings of the 2 analyists that currently disagree with Robert


  • Daina Graybosch of "SVB Leerink" Maintained at Buy with Increased Target to $224 on, Friday, July 29th, 2022
  • William Maughan of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $192 on, Wednesday, July 6th, 2022
Contributing Sources